Abbott gaining traction for FreeStyle Libre study with Lancet publication By Joseph Keenan Sep 13, 2016 10:09am glucose monitoring system Type 1 diabetes Abbott Laboratories MedTech ...

ABBOTT PARK, Ill., March 13 Data published todayin The Lancet from ABSORB, the world's first clinical trial of a fullybioabsorbable drug eluting stent for the treatment of coronary artery ...

A Lancet shows that Abbott’s bioabsorbable drug eluting stent works successfully. It was absorbed into the walls of treated arteries within two years. The two-year data also demonstrated that after ...

The trial showed use of the flash glucose monitoring system dramatically reduced the number of finger sticks while significantly reducing hypoglycemia, including at night. The journal Lancet today ...

ABBOTT PARK, Ill., Aug. 21, 2013 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that it has completed its acquisition of IDEV Technologies, a privately held company focused on developing ...

Data Demonstrate Bioabsorbable Stent Is Absorbed Within Two Years, Leaving Behind Blood Vessels that Appear to Move and Function Similar to Untreated Vessels Abbott Park, Illinois, March 12, 2009 — A ...

Medical laboratory service provider Lancet Group of Labs has unveiled an advanced multi-million shilling lab equipment that cuts waiting time and costs of processing crucial lab tests for patients and ...

ABBOTT PARK, Ill., March 13, 2008 – Data published today in The Lancet from ABSORB, the world’s first clinical trial of a fully bioabsorbable drug eluting stent for the treatment of coronary artery ...

ABBOTT PARK, Ill., Aug. 21, 2013 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that it has completed its acquisition of IDEV Technologies, a privately held company focused on developing ...

The Abbott Architect Ci 8200 at Lancet's Regional Headquaters and Referral Lab in Nairobi. Medical laboratory service provider Lancet Group of Labs has unveiled an advanced multi-million shilling lab ...